Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride use may increase the risk of male breast cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

A new compound was effective for imaging prostate cancer in rats.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Urinary PSA could be an early marker for enlarged prostate.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Men with enlarged prostates often have more severe baldness.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Early hair loss may indicate prostate issues.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.